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GENETIC DISCRIMINATION IN THE WORKPLACE: LESSONS FROM THE 
PAST AND CONCERNS FOR THE FUTURE 
LAURIE A. VASICHEK* 
What happened to me should not happen to anyone, especially in the 
United States.  It is a direct infringement on our fundamental rights to be 
who we are.  No one can help how we are put together.  Only God knows 
that.  The employer, the insurance company or anyone else has no business 
of that knowledge.  That information . . . should not be used against you 
and your family for hiring and firing practices or acceptance and/or denial 
into insurance programs. 
Gary Avary on Burlington Northern 
Santa Fe’s efforts to secretly genetically 
test him1 
Today, the Senate is considering the first major new civil rights bill of the 
new century . . . . We know there are numerous barriers to new discoveries 
that Congress can do little about—the complexities of disease, the 
uncertainties of science, the rarity of true inspiration.  But this is one major 
problem that is entirely within our power to solve.  We can make a 
difference, and we can do it today. 
Senator Edward Kennedy on the 
Genetic Information Nondiscrimination 
Act2 
The law against genetic discrimination has entered a new era.  In April 
2008, after more than a decade of failed efforts,3 Congress passed the 
 
* J.D., University of Minnesota.  Vasichek was one of the attorneys for the Equal Employment 
Opportunity Commission’s litigation against Burlington Northern Santa Fe, challenging 
genetic testing of employees.  Any opinions expressed herein are solely those of the author, 
and do not reflect those of the EEOC.  This paper is based on a presentation at the Health 
Law Symposium, “Living in the Genetic Age: New Issues, New Challenges,” held at the Saint 
Louis University School of Law on March 20, 2009. 
 1. Genetic Nondiscrimination: Implications for Employers and Employees: Hearing 
Before the Subcomm. On Employer-Employee Rel. of the Comm. on Educ. and the Workforce, 
107th Cong. 7-9 (2001) (statement of Gary Avary, Member of the Brotherhood of 
Maintenance of Way Employees union). 
 2. Press Release, Senator Edward Kennedy, Kennedy in Support of Genetic Information 
Nondiscrimination Bill (Apr. 24, 2008), http://www.allamericanpatriots.com/48746785_ 
senator-ted-kennedy-support-genetic-information-no. 
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Genetic Information Nondiscrimination Act (GINA), which President George 
W. Bush signed into law on May 21, 2008.4  GINA’s employment 
provisions became effective on November 21, 2009.5  This new legislation, 
especially when combined with the recent amendments to the Americans 
with Disabilities Act (ADA),6 has great potential to prevent genetic 
discrimination against persons in employment.  Two questions persist, 
however.  First, is the legislation even necessary?  Second, if so, is the 
legislation enough? 
I.  GENETIC DISCRIMINATION: HORROR OR HYPERBOLE 
As efforts to pass legislation in Congress stalled year after year, one 
constant argument of opponents to the bill was that it was unnecessary.  So, 
is there genetic discrimination in the workplace, or is GINA a law looking 
for a fictitious problem? 
The answer depends on who is asked.  Some studies seemed to indicate 
the potential for broad discrimination based upon genetic information.  
According to a 2004 study by the American Management Society, 
companies were genetically testing employees for risk of breast and colon 
cancer, Huntington’s disease, and susceptibility to workplace hazards.  One 
in six of the companies surveyed collected family medical histories of their 
employees.  At least one-half of the companies testing for breast and colon 
cancer risk and Huntington’s disease considered the results in their hiring, 
re-assigning and firing decisions.  One-fifth of the companies use the 
information gleaned from family medical histories, and more than one-half 
use the information from tests regarding susceptibility to workplace hazards 
in their employee decision-making.7 
 
 3. Legislation was first introduced in 1995, and one of its principal proponents has been 
U.S. Representative Louise Slaughter (D-NY).  Rep. Slaughter: Real Action Still Needed on 
Genetics Legislation, US Fed News, July 22, 2004.  For more about Representative 
Slaughter’s efforts, see Politics and Perseverance, An Interview with U.S. Rep. Louise Slaughter, 
D-NY, GENEWATCH, Apr.-May 2009, at 7. 
 4. Genetic Information Nondiscrimination Act of 2008 (GINA), Pub. L. No. 110-233, 
122 Stat. 881(2008) (to be codified in scattered sections of 26 U.S.C., 29 U.S.C., and 42 
U.S.C.); see U.S. Dept. of Energy, Office of Science, Breaking News: GINA Becomes Law 
(May 2008), http://www.ornl.gov/sci/techresources/Human_Genome/elsi/legislat.shtml. 
 5. GINA § 213. 
 6. ADA Amendments Act of 2008 (ADAAA), Pub. L. No. 110-325, 122 Stat. 3553 
(2008) (codified as amended in scattered sections of 42 U.S.C.). 
 7. Susannah Carr, Invisible Actors: Genetic Testing and Genetic Discrimination in the 
Workplace, 30 U. ARK. LITTLE ROCK L. REV. 1, 2-3 (2007); see American Management 
Association, AMA 2004 Workplace Testing Survey: Medical Testing 2 (2004), available at 
http://www.amanet.org/research/pdfs/Medical_testing_04.pdf; see also NAT’L P’SHIP FOR 
WOMEN & FAMILIES ON BEHALF OF THE COAL. FOR GENETIC FAIRNESS, FACES OF GENETIC 
DISCRIMINATION: HOW GENETIC DISCRIMINATION AFFECTS REAL PEOPLE 7 (2004) [hereinafter 
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Another study, from 1996, wherein nearly forty-eight percent of respondents 
who were at risk, presymptomatic, or asymptomatic for a genetic disorder, 
reported that they had experienced some form of discrimination based on 
their risk status.8  Beyond such studies, proponents of legislation barring 
genetic discrimination also pointed to two federal lawsuits—Norman-
Bloodsaw v. Lawrence Berkeley Laboratory9 and EEOC v. Burlington 
Northern Santa Fe Railway10—which both confirmed the existence of secret 
genetic testing by employers on unsuspecting employees. 
Opponents of the legislation, however, asserted that there was no 
evidence, anecdotally or in studies, indicating that genetic discrimination in 
employment was a widespread problem.11  They argued that other laws, 
including Title VII of the Civil Rights Act of 1964, the ADA, and state laws 
already provided protection against genetic discrimination.12  They also 
pointed to the fact that in more than a decade and a half since the ADA was 
adopted, only two genetic testing cases have ever been confirmed, and in 
both cases the employees had legal remedies.13 
There are counters to these arguments, of course.  In the end, GINA 
passed because of a belief that, whatever the extent of current genetic 
discrimination in the workplace, the potential for abuse existed.14  For 
 
FACES OF GENETIC DISCRIMINATION] (describing a 2001 American Management Association 
survey), available at http://www.nationalpartnership.org/site/DocServer/FacesofGenetic 
Discrimination.pdf?docID=971. 
 8. Lisa N. Geller et al., Individual, Family, and Social Dimensions of Genetic 
Discrimination: A Case Study Analysis, 2 SCI. & ENGINEERING ETHICS 71, 74-75 (1996). 
 9. See Norman-Bloodsaw v. Lawrence Berkeley Laboratory, 135 F.3d 1260, 1264 (9th 
Cir. 1998) (reversing the district court’s grant of summary judgment for the defendants on Title 
VII and state and federal privacy claims after employees were subjected to non-consensual 
testing for sensitive medical information). 
 10. EEOC v. Burlington N. & Santa Fe Ry. Co., No. C 01-4013-MWB (N.D. Iowa Apr. 
18, 2001).  Although there were no reported decisions in the case, the underlying facts and 
arguments of the parties were discussed extensively in court filings, public statements, and in 
congressional testimony. 
 11. Employer Advocates Remain Wary of New Bias Law’s Potential Effects, [2008] Daily 
Lab. Rep. (BNA) No. 99 (May 22, 2008) (noting that “management representatives said they 
did not know of any employers that were conducting genetic testing of their workforce or were 
interested in obtaining employees’ genetic data”), http://emlawcenter.bna.com/pic2/em.nsf/ 
id/BNAP-7KMKU9?OpenDocument; see also Mark A. Hall et al., Genetic Screening for Iron 
Overload: No Evidence of Discrimination at One Year, 56 J. FAM. PRAC. 829, 831-33 (2007). 
 12. See infra text accompanying notes 39-40. 
 13. See infra section II A-C. 
 14. See GINA, Pub. L. No. 110-233, § 2(5), 122 Stat. 881, 882-83 (2008) (noting that 
the legislation was passed to assuage the public’s fear of genetic discrimination); see also 
Jeremy Gruber, GINA: How It Came to Pass and What It Does, GENEWATCH, Apr.-May 2009, 
at 4, 4-6 (describing the legislative efforts that culminated in the passage of GINA); Henry T. 
Greely, Banning Genetic Discrimination, 353 NEW ENG. J. MED. 865, 865 (2005). 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
16 SAINT LOUIS UNIVERSITY JOURNAL OF HEALTH LAW & POLICY [Vol. 3:13 
example, advancements in genetic testing are increasing rapidly,15 and tests 
are becoming increasingly easier to obtain.16  Concern about potential 
abuse has led to a marked reluctance by persons to undergo genetic tests.17  
A massive majority of the American public is scared of getting a genetic test 
because people fear that the test results will impact their health insurance or 
their employment.18  As a result, the reluctance of persons to get genetic 
tests interferes with the ability of scientists to conduct research.19 
There’s no doubt the public wanted legislation prohibiting genetic 
discrimination.20  A 2004 study found that ninety-two percent of individuals 
opposed allowing employers access to their genetic information, and eighty 
percent opposed allowing access by insurance companies.21  With scientific 
advancements in the area of human genome research and with the 
increased availability of commercial sources that offer genetic testing 
 
 15. Kathy L. Hudson et al., Perspective: Keeping Pace with the Times — The Genetic 
Information Nondiscrimination Act of 2008, 358 NEW ENG. J. MED. 2661, 2661-62 (2008) 
(indicating that, in 1995, when genetic discrimination legislation was first introduced, there 
were 300 genetic tests available, and in 2008, at the time of GINA’s passage, there were 
more than 1500). 
 16. See GINA § 2(5) (finding that developments in science and law justified adoption of 
GINA); see also Mark A. Rothstein, GINA’s Beauty Is Only Skin Deep: The Law’s Passage May 
Have Been a Step Forward, But It Has Significant Flaws, GENEWATCH, Apr.-May 2009, at 9 
(“To some degree, GINA was enacted to prevent genetic discrimination in the future when 
health records will routinely contain genetic information and genetic testing will be so 
inexpensive that it’s cost-effective to perform it on a widespread basis.”). 
 17. Kathy L. Hudson, Prohibiting Genetic Discrimination, 356 NEW ENG. J. MED. 2021, 
2022 (2007) (“To keep genetic information out of their medical records and out of the hands 
of insurers and employers, patients sometimes pass up genetic testing that could benefit their 
health.”); Amy Harmon, Fear of Insurance Trouble Leads Many to Shun or Hide DNA Tests, 
N.Y. TIMES, Feb. 24, 2008, § 1, at 1; see also Greely, supra note 14, at 867. 
 18. GENETICS & PUB. POLICY CTR., SURVEY: PUBLIC AWARENESS AND ATTITUDES ABOUT 
REPRODUCTIVE GENETIC TECHNOLOGY (2002) (finding that more than nine out of ten persons 
oppose allowing employers access to genetic information, and eight out of ten oppose such 
access by insurers), available at http://www.dnapolicy.org/images/reportpdfs/PublicAwareness 
AndAttitudes.pdf; FACES OF GENETIC DISCRIMINATION supra note 7, at 7. 
 19. See Perry W. Payne, Jr., Genetic Information Nondiscrimination Act of 2008: The 
Federal Answer for Genetic Discrimination, 5 J. HEALTH & BIOMED. L. 33, 38-40 (2009) 
(discussing studies indicating fear of discrimination prevents the use of genetic testing); see 
also FACES OF GENETIC DISCRIMINATION, supra note 7, at 1 (noting that fear of discrimination 
prevents individuals from participating in research, thereby slowing the pace of scientific 
progress). 
 20. See GINA, Pub. L. No. 110-233, § 2(5), 122 Stat. 881, 882-83 (2008) (noting that 
the legislation was passed to protect the public’s fear of genetic discrimination). 
 21. FACES OF GENETIC DISCRIMINATION, supra note 7, at 7.  See Carr, supra note 7, at 3 
(noting that in a 1997 study, eighty-five percent of the respondents “felt that employers should 
be prohibited from obtaining information about an individual’s genetic conditions and 
predispositions”). 
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services, the concern over possible misuse of genetic information has 
become heightened.22  With GINA, the public got what they wanted—at 
least as far as it pertains to employment and health insurance. 
II.  THE LAWS AS THEY EXIST REGARDING GENETIC TESTING IN EMPLOYMENT 
GINA does not supplant other state and federal laws that provide more 
protection to employees.23  GINA, therefore, must be read in light of the 
backdrop of the other state and federal laws that prohibit employment 
discrimination. 
A. Title VII 
Title VII of the Civil Rights Act of 1964 prohibits employment 
discrimination based upon race, sex, color, national origin and religion.24  
Title VII is invoked in genetic testing cases when the employer singles out a 
protected group for testing, or uses tests that have a disparate impact upon 
one protected group.25 
The classic case of Title VII coming into play in a genetic testing case 
arose in Norman-Bloodsaw v. Lawrence Berkeley Laboratory.26  Lawrence 
Berkeley Laboratory was a research facility operated by state and federal 
agencies.27  Employees contended that, in the course of their mandatory 
entrance exams, Lawrence Berkeley Laboratories secretly tested the 
employees’ blood and urine for syphilis, the sickle cell trait, and pregnancy, 
without the employees’ knowledge or consent.28  The employees brought 
suit under the ADA and Title VII, and asserted violations of their 
constitutional rights to privacy under the federal and state constitutions.29  
The employees’ claim under the ADA, which is the only statute upon which 
they relied that contained provisions restricting an employer’s ability to 
conduct medical tests on employees,30 failed in the district court and in the 
Ninth Circuit Court of Appeals because the medical exams were conducted 
after offers of employment were made but before the employees started 
 
 22. See FACES OF GENETIC DISCRIMINATION, supra note 7, at 1. 
 23. GINA § 209(a). 
 24. Civil Rights Act of 1964, 42 U.S.C. § 2000e-2 (2006). 
 25. See Griggs v. Duke Power Co., 401 U.S. 424, 424 (1971) (finding in favor of 
African-American employees that it was in violation of Title VII of the Civil Rights Act of 1964 
to require them to submit a high school diploma or pass intelligence tests in order to transfer 
positions as such information did not provide a reasonable measure of job performance). 
 26. Norman-Bloodsaw v. Lawrence Berkeley Laboratory, 135 F.3d 1260, 1260 (9th Cir. 
1998). 
 27. Id. at 1264. 
 28. Id. 
 29. Id. 
 30. Americans with Disabilities Act, 42 U.S.C. §12112(d) (2006). 
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work.31  While the ADA restricts employers from conducting medical 
examinations before an offer of employment32 and confines tests upon 
current employees to those situations where the test is job-related and 
consistent with business necessity,33 there are few restrictions on the scope of 
examinations conducted after a contingent offer of employment has been 
made and before the employee starts work.34  As long as an employer tests 
everyone in the incoming job categories, maintains the confidentiality of the 
information, and complies with the ADA’s other provisions—including its 
prohibition against discrimination based upon disability—an employer’s 
tests do not need to be job-related under the ADA at that stage.35 
In Norman-Bloodsaw, the plaintiffs were allowed to proceed with their 
constitutional claims, which were of a unique basis because the employer 
was operated by state and federal agencies.36  The Title VII claim was able 
to proceed because Lawrence Berkeley conducted the genetic test for sickle 
cell trait only on African Americans.37  The Title VII claim was also allowed 
to proceed on sex discrimination grounds because the pregnancy test was 
only performed on women.38 
Thus, Title VII is a possible check to genetic tests and discrimination, but 
it is limited in its impact.  Title VII will apply where the employer is selecting 
persons to screen based upon their protected status, such as race or sex, or 
screening for a genetic condition that is disproportionately linked to a 
specific population or sex.  A Title VII claim would arise, for example, if an 
employer was screening only women for mutations on the BRCA1 or BRCA2 
genes,39 which indicate an increased risk for developing breast cancer.40  
Similarly, a Title VII disparate impact claim could be asserted based on race 
 
 31. Norman-Bloodsaw v. Lawrence Berkeley Laboratory, 135 F.3d 1260, 1273-74 (9th 
Cir. 1998). 
 32. 42 U.S.C. § 12112(d)(2). 
 33. 42 U.S.C. § 12112(d)(4)(A). 
 34. 42 U.S.C. § 12112(d)(3). 
 35. Norman-Bloodsaw v. Lawrence Berkeley Laboratory, 135 F.3d 1260, 1273 (9th Cir. 
1998); see also EEOC, ADA ENFORCEMENT GUIDANCE: PREEMPLOYMENT DISABILITY-RELATED 
QUESTIONS AND MEDICAL EXAMINATIONS (1995), available at http://www.eeoc.gov/policy/ 
docs/preemp.html.  GINA changes this result.  See infra section III. 
 36. Norman-Bloodsaw v. Lawrence Berkeley Laboratory, 135 F.3d 1260, 1268-71 (9th 
Cir. 1998) (discussing federal and state constitutional claims). 
 37. Id. at 1272. 
 38. Id. 
 39. See Wroblewski v. Lexington Gardens, Inc., 448 A.2d 801, 806-07 (1982) (holding 
that inquiring into urogenital health of women, but not men, violated state employment 
discrimination law). 
 40. NAT’L CANCER INST., FACT SHEET: BRCA1 AND BRCA2: CANCER RISK AND GENETIC 
TESTING 1 (2009), http://www.cancer.gov/images/documents/abcb7812-a132-4e78-a532-f0 
02c92fa9b9/fs3_62.pdf. 
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if the employer was screening out applicants whose tests showed the sickle 
cell trait, because this would disproportionately exclude African Americans.41  
A claim could also be based on national origin if the employer was 
screening out carriers for Tay-Sachs because it would disproportionately 
exclude Ashkenazi Jews (those of Eastern European descent).42  Most other 
genetically based conditions will not trigger a disparate impact claim 
because such conditions may not be disproportionately linked to a protected 
class. 
B. State Laws 
In addition to Title VII, there are also state laws that protect employees.  
Most states have laws against genetic discrimination in one form or 
another.43  However, these laws vary widely in their protection.  Some do 
not cover employment and are limited to insurance.44  Others prohibit 
employers from firing employees because of genetic conditions, but do not 
bar or restrict employers from requesting the information.45  Only a minority 
of the state laws provide for a private cause of action.46  Thus, this 
patchwork of state laws, with its limited ability to allow for private 
enforcement, does not provide for an effective barrier against unwarranted 
genetic testing and discrimination in employment. 
 
 41. See EEOC Dec. No. 81-8, 2 EMPL. PRAC. GUIDE (CCH) 6764 (1980) (finding that 
rejecting all applicants based on sickle cell anemia violated Title VII). 
 42. Victor Ctr. for Jewish Genetic Disease, Ashkenazi Jewish Genetic Diseases, 
http://www.jewishvirtuallibrary.org/jsource/Health/genetics.html (last visited Feb. 11, 2010); 
see also Mark A. Rothstein, Employee Selection Based on Susceptibility to Occupational 
Illness, 81 MICH. L. REV. 1379, 1453-54 (1983) (discussing occurrence of G-6-PD deficient 
individuals in different populations and concluding that G-6-PD screening would have a 
disparate impact based on race, sex and national origin). 
 43. Hudson, supra note 17, at 2021-22 (“[Thirty-five] states have laws against genetic 
discrimination in employment, and [forty-seven] have laws against genetic discrimination in 
health insurance.”); Nat’l Conference of State Legislatures, Genetic Employment Laws 
(identifying thirty-five states with laws prohibiting genetic discrimination in hiring, firing, and/or 
terms, conditions or privileges of employment, but only fourteen with specific penalties against 
employers), http://www.ncsl.org/IssuesReasearch/Health/GeneticEmployment/Laws/tabid/142 
80/Default.aspx (last visited Feb. 11, 2010). 
 44. See Hudson, supra note 17, at 2021 (noting that no law directly protects the use of 
genetic information by employers and that “additional clarification is needed to ensure that 
genetic information cannot be used to discriminate in employment decisions such as hiring, 
firing, job assignments, and promotions . . . ”). 
 45. U.S. Dep’t of Energy, Human Genome Project Information: Genetics Privacy and 
Legislation, http://www.ornl.gov/sci/techresources/Human_Genome/elsi/legislat.shtml (last 
visited Feb. 11, 2010). 
 46. See National Conference of State Legislatures, Genetic Nondiscrimination in Health 
Insurance Laws Enforcement Provisions (2008), http://www.ncsl.org/default.aspx?tabid= 
14279. 
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C. Americans with Disabilities Act 
In the employment context, there also is the Americans with Disabilities 
Act.  As mentioned earlier, the ADA restricts medical examinations of 
applicants and employees.47  In short, the employer (1) cannot conduct 
medical examinations prior to a conditional offer of employment; (2) can 
conduct a medical examination after a conditional offer of employment has 
been made, even if it is not job-related; and (3) can conduct such exams of 
current employees only when the examination is job-related and consistent 
with business necessity.48  Even if the employer is permitted to require the 
medical examination, the employer cannot use the information obtained to 
discriminate against a qualified individual with a disability.49 
As noted, the ADA’s restrictions on employers conducting genetic tests 
on incoming employees are limited, as shown in Lawrence Berkeley 
Laboratory.50  More protection exists during the employment relationship 
because the tests must be job-related and consistent with business necessity.  
To date, the only suit to challenge a genetic test performed on current 
employees on the basis that it was an unlawful medical exam and 
constituted discrimination based on disability was the EEOC lawsuit against 
Burlington Northern Santa Fe Railway (BNSF).51 
In EEOC v. Burlington Northern Santa Fe Railway, BNSF performed 
genetic tests on employees who had made internal claims of work-related 
carpal tunnel syndrome.52  The BNSF employees were not told that they 
were being genetically tested.  Instead, BNSF merely told them that, “to 
ascertain whether the . . . carpal tunnel syndrome [was] ‘work-related,’ the 
employee must undergo medical testing ‘to ensure that all possible 
contributing causes of [the] condition have been evaluated.’”53  Although 
 
 47. 42 U.S.C. §12112(d) (2006). 
 48. 42 U.S.C. § 12112(d)(2)(A)-(4)(A) (2006); 29 C.F.R. § 1630.14(a)-(c) (2009). 
 49. 29 C.F.R. § 1630.14(b)(3) (2009) (“If certain criteria are used to screen out an 
employee or employees with disabilities as a result of such an examination or inquiry, the 
exclusionary criteria must be job-related and consistent with business necessity, and 
performance of the essential job functions cannot be accomplished with reasonable 
accommodation . . . .”); see also 42 U.S.C. §12112(d)(3)(C) (2006) (noting the only three 
instances when the information may be used). 
 50. Norman-Bloodsaw v. Lawrence Berkeley Laboratory, 135 F.3d 1260, 1273 (9th Cir. 
1998) (stating that the ADA places no restriction on the scope of employment entrance 
examinations). 
 51. EEOC v. Burlington N. & Santa Fe Ry. Co., No. C 01-4013-MWB (N.D. Iowa Apr. 
18, 2001). 
 52. Sam Anderson, When Science Fiction Becomes Fact, GENEWATCH, Apr.-May 2009, at 
11. 
 53. EEOC’s Memorandum in Support of Petition for a Preliminary Injunction at 2, EEOC 
v. Burlington N. & Santa Fe R.R., No. C 01-4013-MWB (N.D. Iowa Apr. 18, 2001) 
[hereinafter EEOC’s Memorandum in Support of Preliminary Injunction]. 
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the employees were told that there would be “laboratory testing,” they were 
not told that BNSF’s doctor would be drawing a number of vials of blood 
that would be shipped to a genetic testing facility in Massachusetts, where it 
would be tested to determine whether there was a “submicroscopic 1.5 
million base pair DNA deletion on the short arm of chromosome 17.”54  
According to information from the genetic testing facility, “this deletion is 
‘suggestive’ of a rare genetic condition called Hereditary Neuropathy with 
liability Pressure Palsies (‘HNPP’).”55 
HNPP is not a common condition, occurring only in 1 out of 20,000 
persons.56  “[It] is a slowly progressive, hereditary, neuromuscular disorder 
which makes an individual susceptible to nerve injury from pressure, stretch 
or repetitive use.”57  The typical onset for HNPP is adolescence or early 
adulthood, and the problem areas include the wrists, elbows, and knees.58  
It usually does not present with carpal tunnel alone;59 it is accompanied by 
other conditions, like drop foot.60  The mutation is very unlikely to be found 
in work-related cases of carpal tunnel syndrome.61  Francis Collins, who led 
the Human Genome Project, called the test as used by BNSF “junk 
science.”62  The scientist who developed the test said that he wished that 
BNSF had called him, because he would have told BNSF to save its 
money.63 
The fact that BNSF was genetically testing its employees was discovered 
by accident.64  One of the employees slated to be tested, Gary Avary, was 
talking to another employee who had been tested.65  The employee told 
 
 54. Id. 
 55. Id. at 3. 
 56. A Newshour with Jim Lehrer: Genetic Testing (Online Focus broadcast June 7, 2001) 
[hereinafter Newshour], available at http://www.pbs.org/newshour/bb/health/jan-june01/ 
genetest_06-07.html. 
 57. The University of Chicago Jack Miller Center for Peripheral Neuropathy, Hereditary 
Neuropathy with Liability to Pressure Palsies (HNPP), http://millercenter.uchicago.edu/learn 
aboutpn/typesofpn/hereditary/hnpp.shtml (last visited Feb. 11, 2010).  Welcome to the 
Hereditary Neuropathy with Liability to Pressure Palsies or HNPP Website, http://www.hnpp. 
org/ (last visited Feb. 11, 2010). 
 58. See Maureen Horton, More About HNPP, http://www.charcot-marie-tooth.org/about_ 
cmt/hnpp.php (last visited Feb. 6, 2010). 
 59. Newshour, supra note 56. 
 60. Id. 
 61. EEOC’s Memorandum in Support of Preliminary Injunction, supra note 53, at 3. 
 62. Newshour, supra note 56. 
 63. Lisa Girion, Nurse Derails Genetic Testing: Wife of Railroad Worker Sparks Probe that 
May Have Wide Implications, L.A. TIMES, Feb. 25, 2001 at W1 (“If they had just bothered to 
call me I could have saved them a lot of money and a lawsuit they richly deserve.”). 
 64. Anderson, supra note 52, at 11. 
 65. Id. 
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Avary that seven vials of blood were taken during his examination.66  Avary 
informed his wife, Janice, who was a nurse and who could not understand 
why so many vials of blood were being drawn.67  She pursued her concerns, 
first calling BNSF’s medical liaison, who after being pressed, told her that 
the tests included “genetic tests.”68  Janice then spoke to BNSF’s chief 
medical officer, who wanted to know who had revealed the tests.69  He 
ultimately conceded that a genetic test for HNPP was going to be 
performed.70  Avary objected and refused to take the test.71  BNSF accused 
him of insubordination and of violating BNSF’s safety rules.72  BNSF 
scheduled him to appear before an “investigation” panel for a hearing with 
the possible result of termination.73  Avary and other employees went to both 
their union and the EEOC, which consequently sought an injunction to stop 
the testing within the same week.74 
The case captured the public’s attention.  It was in People Magazine, on 
Good Morning America, The Lehrer Report, and it was featured in a PBS 
documentary called “Bloodlines: Technology Hits Home.”75  It became the 
virtual poster child for the need for a federal law that could protect against 
genetic testing.  Part of the attention arose by virtue of its timing: the same 
week in which the EEOC moved for a preliminary injunction against BNSF, 
the Human Genome Project announced the draft sequence and initial 
analysis of the human genome.76  Some of the interest stemmed from the 
secretive nature of the testing; and in legal fields, some of the interest arose 
from the problems that the case revealed about the reach of the ADA with 
regard to genetic testing and discrimination. 
 
 66. Id. 
 67. Id. 
 68. EEOC’s Memorandum in Support of Preliminary Injunction, supra note 53, at 4. 
 69. Id. 
 70. Id. 
 71. Id. at 5; Anderson, supra note 52, at 11, 13. 
 72. Anderson, supra note 52, at 11, 13. 
 73. See id. 
 74. EEOC’s Memorandum in Support of Preliminary Injunction, supra note 53, at 2 
(“During the past week, the EEOC learned that BNSF recently instituted a policy whereby any 
employee who claims to have developed carpal tunnel syndrome as a result of BNSF’s 
working conditions is forced to undergo genetic testing.”). 
 75. Nick Charles, Telling Them No, PEOPLE, July 9, 2001, at 81; Good Morning America: 
Interview with Diane Sawyer (ABC television broadcast April 18, 2001); Newshour, supra note 
56; BLOODLINES: TECHNOLOGY HITS HOME (Backbone Media, 2003).  
 76. See EEOC’s Memorandum in Support of Preliminary Injunction, supra note 53.  See 
Press Release, Nat’l Human Genome Research Inst., International Human Genome 
Sequencing Consortium Publishes Sequence and Analysis of the Human Genome (Feb. 12, 
2001), http://www.genome.gov/10002192. 
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In the case itself, the EEOC argued first that the test violated the ADA 
provisions on medical examinations of current employees.77  The EEOC 
contended that before a test could be conducted, it had to be job-related 
and consistent with business necessity.78  It further asserted, consistent with 
EEOC guidance,79 that an employer could conduct such a test only if it was 
testing to see whether a condition interfered with the employee’s ability to 
perform the essential functions of the job, or whether he posed a direct 
threat to the safety of himself or others.80  The EEOC asserted that BNSF 
was looking for the cause of the carpal tunnel, and not whether the 
condition posed a threat to the employee.81  Consequently, the EEOC 
argued the test was not job-related or backed by business necessity.82 
BNSF, however, asserted that the genetic test was permissible under the 
ADA.  BNSF contended that there was no evidence it intended to take 
adverse action against the workers as a result of the test.83  “Burlington 
Northern said it was merely ‘trying to determine whether the injuries were 
work-related so that we could fix it.’”84  BNSF asserted that the company 
was obligated by federal law to determine whether the injuries were work-
related.85 
BNSF’s defenses raised a host of unresolved issues under the ADA, such 
as—even assuming that an employer could argue that its medical tests were 
 
 77. EEOC’s Memorandum in Support of Preliminary Injunction, supra note 53, at 9.  See 
42 U.S.C. § 12112(d)(4)(A) (2006); 29 C.F.R. § 1630.13(b) (2008); see also U.S. EQUAL 
EMPLOYMENT OPPORTUNITY COMM’N, ENFORCEMENT GUIDANCE:  DISABILITY-RELATED INQUIRIES 
AND MEDICAL EXAMINATIONS OF EMPLOYEES UNDER THE AMERICANS WITH DISABILITIES ACT (ADA) 4 
(2000) [hereinafter EEOC ADA ENFORCEMENT GUIDANCE] (noting that medical examinations 
include “blood, urine, saliva, and hair analyses to detect disease or genetic markers”), 
http://www.eeoc.gov/policy/docs/guidance-inquiries.html. 
 78. EEOC’s Memorandum in Support of Preliminary Injunction, supra note 53, at 9-10.  
See 42 U.S.C. § 12112(d)(4)(A) (2006); see also 29 C.F.R. § 1630.14(c) (2008). 
 79. EEOC ADA ENFORCEMENT GUIDANCE, supra note 77 at 6; U.S. EQUAL EMPLOYMENT 
OPPORTUNITY COMM’N, EEOC ENFORCEMENT GUIDANCE ON THE AMERICANS WITH DISABILITIES 
ACT AND PSYCHIATRIC DISABILITIES: NOTICE CONCERNING THE AMERICANS WITH DISABILITIES ACT 
AMENDMENTS ACT OF 2008, U.S. Equal Employment Opportunity Commission, available at 
http://www.eeoc.gov/policy/docs/psych.html (last visited Feb. 11, 2010). 
 80. EEOC’s Memorandum in Support of Preliminary Injunction, supra note 53, at 9-10. 
 81. Id. at 10. 
 82. Id. at 9-10. 
 83. Indeed, the EEOC did not contend otherwise except for its assertions that BNSF 
intended to retaliate against Gary Avary based upon his good faith refusal to take the genetic 
test.  See EEOC Memorandum in Support of its Preliminary Injunction, supra note 53, at 15-
16. 
 84. Art LeClair, Railworkers Win Against Genetic Testing, SOCIALIST VIEWPOINT, May 
2001, http://www.socialistviewpoint.org/may_01/may_01_9.html. 
 85. Stephen Fink, EEOC v. BNSF: The Risks and Rewards of Genetic Exceptionalism, 42 
WASHBURN L.J. 525, 527-28 (2003). 
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job-related and consistent with business necessity—whether it could keep the 
tests secret from the employee.  There is nothing in the ADA that explicitly 
requires notice to and consent by the employees to the specific tests that the 
employer conducts.86  However, notice and consent arguably are assumed 
in the ADA’s provisions on prohibited medical testing.  An employee would 
be permitted to protest taking tests that he or she believed in good faith 
violated the ADA, and would be protected from retaliation for those 
protests.87 
The Burlington Northern case ultimately settled for $2.2 million and 
broad equitable relief, including an end to genetic testing by BNSF and the 
development of a protocol for handling the genetic samples and test 
results.88  The early settlement left unknown whether the courts would have 
adopted the EEOC’s position that BNSF’s genetic testing violated the ADA’s 
restrictions on medical examinations of current employees.  In even more 
doubt is the ultimate resolution of the EEOC’s additional claim89 that BNSF 
“regarded” the tested employees as having disabilities, and by subjecting 
them to special genetic testing, BNSF imposed upon them different terms 
and conditions of employment because of their disabilities.  The EEOC 
asserted that, by singling out those employees with claims of carpal tunnel 
syndrome, BNSF presumed that these employees had or potentially had a 
chromosomal defect leading to carpal tunnel.90  The EEOC argued that 
BNSF therefore regarded the employees as having conditions that would 
substantially limit them in the major life activities of performing manual tasks 
and working, as would carpal tunnel syndrome.91 
The EEOC has long taken the position that employers who discriminate 
against individuals based upon genetic information are regarding the 
individuals as having impairments that substantially limit a major life 
activity.92  Considerable doubt has been expressed as to whether courts 
 
 86. See 42 U.S.C. § 12112 (2006). 
 87. See 42 U.S.C. § 12203 (2006); see also Rothstein, supra note 42, at 1466-67 
(discussing that an employer is barred from retaliating against an employee based upon the 
employee’s refusal to take tests believed in good faith by the employee to be discriminatory). 
 88. Press Release, U.S. Equal Employment Opportunity Comm’n, EEOC and BNSF Settle 
Genetic Testing Case under Americans with Disabilities Act (May 8, 2002), http://www.eeoc. 
gov/press/5-8-02.html. 
 89. EEOC’s Memorandum in Support of Preliminary Injunction, supra note 53, at 13-15; 
See 42 U.S.C. § 12102(2) (2006). 
 90. EEOC’s Memorandum in Support of Preliminary Injunction, supra note 53, at 12. 
 91. Id. at 14. 
 92. See 136 Cong. Rec. H4623 (daily ed. July 12, 1990) (statement of Rep. Owens).  
This part of the definition of “disability” applies to individuals who are subjected to 
discrimination on the basis of genetic information relating to illness, disease, or other 
disorders.  Covered entities that discriminate against individuals on the basis of such genetic 
information are regarding the individuals as having impairments that substantially limit a 
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would accept the EEOC’s position, however.93  Under the federal law 
against disability discrimination—as it existed prior to ADA amendments 
effective in January 2009—employers could argue that they were not 
regarding the employee as currently restricted in major life activities, such as 
lifting, walking, and performing manual tasks,94 and therefore, the person 
was not regarded as having a disability.95  Prior to the recent ADA 
Amendments Act (ADAAA), courts concluded that individuals who 
manifested HIV,96 breast cancer,97 heart disease,98 diabetes,99 and 
epilepsy,100 for example, were not disabled because the limitations imposed 
by the conditions were not severe enough nor did they affect the persons’ 
abilities to perform major life functions for the requisite period of time.  It is 
possible, therefore, that an employer that based its decision exclusively upon 
genetic information could escape liability under the ADA. 
 
major life activity.  Those individuals, therefore, are covered by the third part of the definition 
of “disability.”  Id. at H4624-25 (statement of Rep. Edwards); id. at H4627 (statement of Rep. 
Waxman).  U.S. EQUAL EMPLOYMENT OPPORTUNITY COMM’N, SECTION 902 DEFINITION OF THE 
TERM DISABILITY:  NOTICE CONCERNING THE AMERICANS WITH DISABILITIES ACT AMENDMENTS ACT 
OF 2008 § 902.8(a), http://www.eeoc.gov/policy/docs/902cm.html (last visited Feb. 6, 
2009). 
 93. See, e.g., William J. McDevitt, I Dream of GINA: Understanding the Employment 
Provisions of the Genetic Information Nondiscrimination Act of 2008, 54 VILL. L. REV. 91, 104 
(2009) (“[T]he applicability of the ‘regarded as’ prong of the ADA’s definition of ‘disability’ to 
individuals who are predisposed to genetically related diseases is tenuous.”); Mark A. 
Rothstein, Currents in Contemporary Ethics: GINA, the ADA, and Genetic Discrimination in 
Employment, 36 J.L. MED. & ETHICS 837, 838 (2008) (noting that “individuals with a genetic 
predisposition to future illness are probably not covered by the ADA”). 
 94. 29 C.F.R. § 1630.2(i) (2008). 
 95. 29 C.F.R. § 1630.2(l) (2008). 
 96. St. John v. NCI Bldg. Sys., Inc., 537 F. Supp. 2d 848, 861-62 (S.D. Tex. 2008). 
 97. See, e.g., Garrett v. Univ. of Ala. at Birmingham Bd. of Trs., 507 F.3d 1306, 1309, 
1315 (11th Cir. 2007).  This case ultimately reached the Supreme Court, which held against 
the employee on Eleventh Amendment grounds. 
 98. Taylor v. Nimock’s Oil Co., 214 F.3d 957, 960-61 (8th Cir. 2000) (noting that 
employee’s heart disease recovery period did not qualify as substantial limitation on a major 
life activity). 
 99. Diaz Rivera v. Browning-Ferris Indus. of P.R., Inc., 626 F. Supp. 2d 244, 257 (D. P.R. 
2009). 
 100. Fred Mancini v. Union Pacific R.R. Co., No. 02-36151, 2004 U.S. App. LEXIS 8213, 
at *4-5 (9th Cir. Apr. 23, 2004) (noting that epilepsy is not a disability for ADA purposes 
where its “manifestations . . . are ‘totally controlled’ through the consistent use of 
medication”). 
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D. Amendments to the ADA 
The ADA was amended, however, effective as of January 1, 2009, by 
the ADA Amendments Act of 2008 (ADAAA).101  The ADAAA allows for a 
better argument that someone who is subjected to differential treatment 
because he or she has a genetic condition—even though not currently or 
completely manifested—is regarded as having a disability.102  The 
amendments to the ADA are sweeping and beyond the scope of this 
discussion.  However, as a brief overview, the amendments reversed several 
Supreme Court opinions, which contracted the ADA’s protections, and are 
intended to make it easier for an individual to show that he or she has a 
disability under the ADA.103  For example, the definition of “major life 
activities” was expanded to include “major bodily functions” such as 
“functions of the immune system, normal cell growth, digestive, bowel, 
bladder, neurological, brain, respiratory, circulatory, endocrine, and 
reproductive functions.”104  Further, under the amended Act, persons are to 
be considered in their unmitigated state, without regard to whether their 
condition is controlled by treatments such as medications or prosthetics.105  
Persons who have a condition that is episodic or in remission are to be 
considered as though the condition is active as long as it substantially limits 
a major life activity while active.106  Therefore, the standard for whether 
someone is substantially limited is to be lower than previously asserted.107 
In September 2009, the EEOC issued a Notice of Proposed Rulemaking 
(NPRM), setting forth proposed regulations interpreting the new ADA 
amendments.108  The proposed regulations accompanying the NPRM, 
 
 101. ADA Amendments Act of 2008, Pub. L. No. 110-325, § 1, § 8, 122 Stat. 3553 
(2008) (amending scattered sections of 42 U.S.C.). 
 102. ADA Amendments Act of 2008 § 4(a), 122 Stat. at 3555 (to be codified at 42 U.S.C. 
§ 12102(3)(A)). 
 103. ADA Amendments Act of 2008 § 2(a)(2)-(5), 122 Stat. at 3554 (declaring that the 
ADAAA overturns Toyota Motor Manufacturing, Kentucky, Inc. v. Williams, 534 U.S. 184, 
197-98 (2002) and Sutton v. United Air Lines, Inc., 527 U.S. 471, 488 (1999)); see also 
Murphy v. United Parcel Service, Inc., 527 U.S. 516, 521 (1999); Albertson’s, Inc. v. 
Kirkingburg, 527 U.S. 555, 564 (1999). 
 104. ADA Amendments Act of 2008 § 4(a), 122 Stat. at 3553, 3555 (to be codified at 42 
U.S.C. § 12102(2)(B)). 
 105. ADA Amendments Act of 2008 § 4(a), 122 Stat. at 3556 (to be codified at 42 U.S.C. 
§ 12102(4)(E)(i)(I)). 
 106. ADA Amendments Act of 2008, Pub. L. No. 110-325, § 4(a), 122 Stat. 3556 (2008) 
(to be codified at 42 U.S.C. § 12102(4)(D)). 
 107. ADA Amendments Act of 2008 § 4(a), 122 Stat. at 3555 (to be codified at 42 U.S.C. 
§ 12102(4)(A)). 
 108. Regulations to Implement the Equal Employment Provisions of the Americans With 
Disabilities Act, as Amended, 74 Fed. Reg. 48,431, 48,431 (proposed Sept. 23, 2009) (to be 
codified at 29 C.F.R. pt. 1630). 
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although not final, suggest that individuals whose genetic conditions have 
manifested will be able to argue that their conditions have affected a major 
life activity.  For example, the proposed regulations published in the Federal 
Register and subject to a comment period,109 provide that “sickle cell 
disease affects functions of the hemic system” and therefore is a major life 
activity because it involves the operation of a bodily function.110 
For discrimination based solely upon genetic makeup where there is no 
and may never be any manifested condition, the most important change 
comes in the definition of whether an employer regards the individual as 
having a disability.  Prior to the ADAAA, the individual had to establish that 
the employer regarded the individual as having an impairment that 
substantially limited a major life activity.111  Now, it is only necessary for the 
employee to show that the employer regarded the employee as having an 
actual or perceived mental or physical impairment, and that the employee 
was subjected to discrimination as a result.  Consequently, the employee 
does not have to show that the employer perceived him or her as 
substantially limited in a major life activity. 
An employee fired for a genetic condition, whether it never manifested 
or became only slightly symptomatic, could argue that the employer 
perceived him or her as having an impairment.  The regulations define 
impairment to mean: 
(1) Any physiological disorder, or condition, cosmetic disfigurement, or 
anatomical loss affecting one or more of the following body systems: 
neurological, musculoskeletal, special sense organs, respiratory (including 
speech organs), cardiovascular, reproductive, digestive, genito-urinary, 
hemic and lymphatic, skin, and endocrine; or 
(2) Any mental or psychological disorder, such as mental retardation, 
organic brain syndrome, emotional or mental illness, and specific learning 
disabilities.112 
 
 109. Id.  The deadline for written comments on the rulemaking was on or before Nov. 23, 
2009.  Id. 
 110. Id. at 48,440. 
 111. See Sutton v. United Air Lines, Inc., 527 U.S. 471, 490 (1999) (“Under subsection 
(C), individuals who are ‘regarded as’ having a disability are disabled within the meaning of 
the ADA.  Subsection (C) provides that having a disability includes “being regarded as 
having,” “a physical or mental impairment that substantially limits one or more of the major 
life activities of such individual.”  There are two apparent ways in which individuals may fall 
within this statutory definition: (1) a covered entity mistakenly believes that a person has a 
physical impairment that substantially limits one or more major life activities, or (2) a covered 
entity mistakenly believes that an actual, nonlimiting [sic] impairment substantially limits one or 
more major life activities.”) (internal citations omitted). 
 112. 29 C.F.R. § 1630.2(h) (2009).  The regulations proposed in the EEOC’s recent 
NPRM would leave this regulation unchanged except for substituting “intellectual disability” for 
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An applicant or employee today could argue that if he or she were 
discriminated against based on a genetic condition that the employer 
perceived the person as having an impairment.  For example, a woman 
discharged for having a mutation on the BRCA1 or BRCA2 gene could 
argue that the employer perceived her as having a disorder that substantially 
affects a body system, and therefore, the employer regarded her as having a 
disability. 
It is unlikely that courts will be called to decide the issue of the 
asymptomatic victim, however, because November 2009 began the brave 
new world of GINA.  Under GINA, there is a much clearer and simpler 
answer. 
III.  THE BRAVE NEW WORLD OF GINA 
GINA prohibits genetic discrimination in both health insurance and 
employment.  Title II specifically applies to employment and bars the 
intentional acquisition of genetic information about applicants or 
employees, prohibits employment decisions based on genetic information, 
and imposes strict confidentiality requirements on the handling of genetic 
information.113 
The EEOC is the federal agency tasked with enforcement of Title II.114  
On March 2, 2009 the EEOC published a Notice of Proposed Rulemaking 
(NPRM), setting out a summary and text of the EEOC’s proposed 
implementing regulations.115  It received numerous comments on the 
proposed regulations.116  Subsequently, on August 6, 2009, the 
Commissioners approved proposed GINA regulations, whereupon the 
EEOC submitted them to the White House Office of Management and 
Budget (OMB) for review.117  The content of the regulations submitted to 
 
“mental retardation.”  Regulations to Implement the Equal Employment Provisions of the 
Americans with Disabilities Act, as Amended, 74 Fed. Reg. at 48,432. 
 113. GINA, Pub. L. No. 110-233, §§ 201-13, 122 Stat. 905 (2008) (to be codified at 42 
U.S.C. §§ 2000ff – 2000ff-11); Pub. L. No. 110-233, §§ 202-06 (to be codified at 42 U.S.C. 
§§2000ff-1 – 2000ff-5. 
 114. GINA, § 207(g) (to be codified at 42 U.S.C. § 2000ff-6) (incorporating enforcement 
provisions of Title VII). 
 115. Regulations Under the Genetic Information Nondiscrimination Act of 2008, 74 Fed. 
Reg. 9056, 9056 (proposed March 2, 2009) (to be codified at 29 C.F.R. pt. 1635). 
 116. Genetic Discrimination: EEOC Receives Varying Advice on Tweaking Its Proposed 
Rules Under Genetic Bias Law, [2009] Daily Lab. Rep. (BNA) No. 90, at C-1 (May 13, 2009) 
(summarizing comments).  The comments are posted without change at 
http://www.regulations.gov, and can be accessed through the Regulatory Information Number 
(RIN) for the rulemaking, RIN 3046-AA84. 
 117. Genetic Discrimination: EEOC Clears GINA Rule for OMB Review, [2009] Daily Lab. 
Rep. (BNA) No.151, at A-18 (Aug. 10, 2009). 
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OMB, including the extent to which changes were made in response to the 
submitted comments, has not yet been made public. 
The employment provisions in Title II are modeled after those in Title VII 
of the Civil Rights Act of 1964.  The enforcement and remedies section in 
GINA incorporates those of Title VII.118  Unlike Title VII, it does not permit 
disparate impact claims,119 although it does provide that a committee be 
formed within six years to consider whether such a cause of action should be 
included in the statute.120 
GINA hinges on the definition of genetic information.  Genetic 
information is broadly defined by GINA and the proposed regulations 
accompanying the EEOC’s NPRM and does not include information about 
the age or sex of the individual:121 
Genetic information means information about (i) [a]n individual’s genetic 
tests; (ii) [t]he genetic tests of that individual’s family members; (iii) [t]he 
manifestation of disease or disorder in family members of the individual 
(family medical history); (iv) [a]n individual’s request for, or receipt of, 
genetic services, or participation in a clinical research that includes genetic 
services by the individual or a family member of the individual; or (v)[t]he 
genetic information of a fetus [including information obtained from assisted 
reproductive services].122 
This definition also lends itself to a number of sub-definitions, such as, 
for example, what is a “genetic test.”  Genetic test is “an analysis of human 
DNA, RNA, chromosomes, proteins, or metabolites that detects genotypes, 
mutations, or chromosomal changes.”123  “An analysis of proteins or 
metabolites that does not detect genotypes, mutations, or chromosomal 
changes is not a genetic test.”124  “A medical examination that tests for the 
presence of a virus that is not composed of human DNA, RNA, 
chromosomes, proteins, or metabolites is not a genetic test.”125 
 
 118. GINA, § 207, 122 Stat. at 914 (to be codified at 42 U.S.C. § 2000ff-6). 
 119. Id. § 207, 122 Stat. at 917 (to be codified at 42 U.S.C. §2000ff-7). 
 120. Id. 
 121. GINA, Pub. L. No. 110-233, §201(3)(c), 122 Stat. 905, 906 (2008) (to be codified 
at 42 U.S.C. §2000ff(4)(C); Regulations Under the Genetic Information Nondiscrimination Act 
of 2008, 74 Fed. Reg. at 9067 (to be codified at 29 C.F.R. pt. 1635.3(c)(2)). 
 122. Regulations Under the Genetic Information Nondiscrimination Act of 2008, 74 Fed. 
Reg. 9056, 9067 (proposed Mar. 2, 2009) (to be codified at 29 C.F.R. pt. 1635.3(c)(1)). 
 123. GINA § 201(7)(A), 122 Stat. at 907 (to be codified at 42 U.S.C. §2000ff); 
Regulations Under the Genetic Information Nondiscrimination Act of 2008, 74 Fed. Reg. at 
9068 (to be codified at 29 C.F.R. pt. 1635.3(f)(1)). 
 124. GINA § 201(7)(B), 122 Stat. at 907 (to be codified at 42 U.S.C. §2000ff); 
Regulations Under the Genetic Information Nondiscrimination Act of 2008, 74 Fed. Reg. at 
9068 (to be codified at 29 C.F.R. pt. 1635.3(f)(1)(i)). 
 125. Regulations Under the Genetic Nondiscrimination Act of 2008, 74 Fed. Reg. at 9068 
(to be codified at 29 C.F.R. pt. 1635.3(f)(1)(ii)). 
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Thus, as the proposed regulations set out, a “test for the presence of 
drug or alcohol is not a genetic test; [although a] test to determine whether 
an individual has a genetic predisposition for alcohol or drug use is a 
genetic test.”126  According to information from the Genetics & Public Policy 
Center, an HIV test would not be considered a genetic test under GINA.  
“Although it is a retrovirus that inserts itself into human DNA, HIV is not itself 
human DNA and measuring its presence does not constitute a genetic test 
under the law’s definition.”127 
Tests that would be covered by this definition would include the test for 
the sickle cell trait in Lawrence Berkeley Laboratory, and the test for the 
deletion on Chromosome 17, which is indicative of HNPP and was at issue 
in Burlington Northern.128  GINA would include tests for BRCA 1/BRCA 2, 
indicating an increased risk of breast cancer, as well as tests for the 
Huntington’s disease mutation; and carrier screening for conditions such as 
cystic fibrosis, spinal muscular atrophy, and fragile X syndrome, as genetic 
tests.129 
Medical history and genetic tests of family members are considered 
genetic information under GINA.130  “Family member” is similarly broadly 
defined as extending to fourth degree relatives, which would include great-
great grandparents and children of cousins.131  Interestingly, by reference to 
another statute, it also includes genetic information of dependents, including 
those who become related through marriage or adoption.132  Consequently, 
the reach of this statute does not restrict its coverage to genetic information 
about the individual but also will reach that of certain family members who 
are not of the same bloodline. 
 
 126. Regulations Under the Genetic Nondiscrimination Act of 2008, 74 Fed. Reg. 9056, 
9068 (proposed Mar. 2, 2009) (to be codified at 29 C.F.R. pt. 1635.3(f)(2)) (emphasis 
added). 
 127. GENETICS & PUB. POLICY CTR., JOHNS HOPKINS UNIV., INFORMATION ON THE GENETIC 
INFORMATION NONDISCRIMINATION ACT (GINA) 2, http://www.dnapolicy.org/resources/What 
GINAdoesanddoesnotdochart.pdf (last visited Feb. 11, 2010). 
 128. Id.  See Norman-Bloodsaw v. Lawrence Berkeley Laboratory, 135 F.3d 1260, 1264-
65 (9th Cir. 1998); EEOC v. Burlington N. & Santa Fe Ry. Co., No. C 01-4013-MWB (N.D. 
Iowa Apr. 18, 2001); EEOC v. Burlington N. & Santa Fe Ry. Co., No. 02-C-0456, slip op. at 
*1 (E.D. Wis. May 8, 1990). 
 129. See GENETICS & PUB. POLICY CTR., supra note 127. 
 130. GINA, Pub. L. No. 110-233, §201(4)(A)(iii), 122 Stat. 905, 906 (2008) (to be 
codified at 42 U.S.C. 2000ff). 
 131. Regulations Under the Genetic Nondiscrimination Act of 2008, 74 Fed. Reg. 9056, 
9067 (proposed Mar. 2, 2009) (to be codified at 29 C.F.R. pt. 1635.3(a)(2)).  See GINA § 
201(4)(A)(iii), 122 Stat. at 906 (to be codified at 42 U.S.C. 2000ff). 
 132. GINA § 201(3)(A), 122 Stat. at 906 (incorporating the definition of “dependent” in 
section 701(f)(2) of ERISA); see Regulations Under the Genetic Nondiscrimination Act of 
2008, 74 Fed. Reg. at 9067 (to be codified at 29 C.F.R. pt. 1635.3(a)(1)). 
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Employers, unions, training programs, and employment agencies 
(“covered entities”) are barred from requesting, requiring, or purchasing 
genetic information of an individual, except for a few exceptions.133  Thus, 
the hole in the ADA that was pointed out by the Lawrence Berkeley 
Laboratory case, where an employer is not constrained from obtaining 
genetic information in the post-offer/pre-placement stage has been plugged 
by GINA.134  Under GINA, a covered entity will not be permitted to take a 
family history at this stage or at any point in the employment relationship 
unless the genetic information falls into one of the few exceptions.135 
A covered entity does not violate GINA’s restrictions regarding obtaining 
genetic information if the entity inadvertently obtained the information.136  
The NPRM addresses supposed “water cooler” talk.  For example, the 
NPRM’s section-by-section analysis and the proposed regulations conclude 
that an employer does not violate GINA when it learns genetic information 
by overhearing a conversation that contains information about someone’s 
family history.137  The proposed regulations also address where an employer 
receives genetic information in response to a question such as, “How is your 
family?”138 
Also, the proposed NPRM regulations recognize that genetic information 
may be inadvertently obtained by a covered entity who seeks other 
information relating to a request for a reasonable accommodation under 
the ADA.139  This recognition by the NPRM responds to concerns that 
covered entities might receive more than they asked for from employees or 
their physicians during the ADA’s interactive process.  The NPRM cautions, 
however, that the covered entities’ requests for medical information should 
 
 133. GINA §§ 202(b), 203(b), 204(b), 122 Stat. at 907-10 (to be codified at 42 U.S.C. 
§2000ff-1(b), §2000ff-2(b), §2000ff-3(b), §2000ff-4(b)); Regulations Under the Genetic 
Nondiscrimination Act of 2008, 74 Fed. Reg. at 9068 (to be codified at 29 C.F.R. pt. 
1635.3(7)). 
 134. See supra text accompanying notes 30-35. 
 135. Regulations Under the Genetic Nondiscrimination Act of 2008, 74 Fed. Reg. at 
9061. 
 136. Regulations Under the Genetic Nondiscrimination Act of 2008, 74 Fed. Reg. 9056, 
9068 (proposed Mar. 2, 2009) (to be codified at 29 C.F.R. pt. 1635.8(b)(1)); GINA, Pub. L. 
No. 110-233, §§ 201, 203-05, 122 Stat. 905, 905-12 (2008) (to be codified at 42 U.S.C. 
§2000ff-1(b)(1), §2000ff-2(b)(1), §2000ff-3(b)(1), §2000ff-4(b)(1)). 
 137. Regulations Under the Genetic Nondiscrimination Act of 2008, 74 Fed. Reg. at 
9061, 9068 (to be codified at 29 C.F.R. pt. 1635.8(b)(1)(i)). 
 138. Regulations Under the Genetic Nondiscrimination Act of 2008, 74 Fed. Reg. at 
9061, 9068 (to be codified at 29 C.F.R. pt. 1635.8(b)(1)(ii)). 
 139. Regulations Under the Genetic Nondiscrimination Act of 2008, 74 Fed. Reg. at 
9061-62, 9068 (to be codified at 29 C.F.R. pt. 1635.8(b)(1)(iii)). 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
32 SAINT LOUIS UNIVERSITY JOURNAL OF HEALTH LAW & POLICY [Vol. 3:13 
not be overbroad, and if they are, genetic information obtained in response 
might not be considered inadvertently obtained.140 
Similarly, GINA exempts information received from employees to 
support a request for leave under the Family Medical Leave Act (FMLA).141  
Employees covered by the FMLA142 can obtain leave to care for a family 
member who has a serious health condition.143  An employer can request 
verification of the need, even though the information obtained may fall 
within the definition of “family medical history.”144 
GINA recognizes that an employer may obtain information from 
commercial or public sources.145  The EEOC’s proposed GINA regulations 
and its section-by-section analysis in its NPRM discuss employers who gain 
genetic information from sources like newspapers and the Internet.146  
Importantly, the regulations prohibit employers from surfing medical 
websites or court records with the intention of obtaining medical 
information.147 
Whether and the extent to which employers are restricted from obtaining 
information from things such as personal web pages and social networking 
sites, remains an open question.148  The EEOC’s NPRM explicitly solicited 
 
 140. Regulations Under the Genetic Nondiscrimination Act of 2008, 74 Fed. Reg. at 
9061-62. 
 141. GINA, Pub. L. No. 110-233, §202(b)(3), 122 Stat. 905, 907-08 (2008) (to be 
codified at 42 U.S.C. 2000ff-1). 
 142. 29 U.S.C. §2611(2)(A) (2006). 
 143. 29 C.F.R. § 825.112 (a)(3) (2006). 
 144. Even if the genetic information was inadvertently or not inappropriately obtained, 
GINA requires that the information be held in confidence.  GINA § 205(b)(3), 122 Stat. at 
912 (to be codified at 42 U.S.C. 2000ff-4).  For example, in litigation, the covered entity 
cannot release the information without a court order.  A discovery request or a stipulation of 
confidentiality will not suffice.  Regulations Under the Genetic Nondiscrimination Act of 2008, 
74 Fed. Reg. 9056, 9063-64, 9069 (proposed Mar. 2, 2009).  Regardless of how the 
information was obtained and regardless of whether the genetic information is regarded as 
“confidential” genetic information, covered entities are absolutely prohibited from using the 
genetic information in making employment decisions. See Regulations Under the Genetic 
Nondiscrimination Act of 2008, 74 Fed. Reg. at 9063-64, 9069.  See supra text 
accompanying notes 130-31. 
 145. GINA § 203(b)(4), 122 Stat. at 909 (to be codified at 42 U.S.C. 2000ff-2).  
Regulations Under the Genetic Nondiscrimination Act of 2008, 74 Fed. Reg. at 9063. 
 146. Regulations Under the Genetic Nondiscrimination Act of 2008, 74 Fed. Reg. at 
9063, 9069 (to be codified at 29 C.F.R. pt. 1635.8(b)(4)). 
 147. Regulations Under the Genetic Nondiscrimination Act of 2008, 74 Fed. Reg. at 
9063, 9069 (to be codified at 29 C.F.R. pt. 1635.8(b)(4)). 
 148. Regulations Under the Genetic Nondiscrimination Act of 2008, 74 Fed. Reg. at 
9063. 
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comment on the issue of personal web pages and social networking sites.149  
Commentators were divided on whether the exception for commercially or 
publicly available material would extend to such information, with business 
groups taking the position that employers should not be penalized for 
material found on the Internet when searching for other purposes, and 
privacy rights groups and employee advocates asserting that the exception 
should not include sites likely to contain such information.150  It is unknown 
whether the proposed regulations submitted to OMB after the comments 
were received address this issue. 
GINA also does not punish an employer who learns about genetic 
information through a voluntary wellness program if certain prerequisites are 
met.151  Wellness programs are those where an employer takes steps to 
encourage employees to engage in activities that will decrease their health 
risks.152  More than sixty percent of companies with 10,000 or more 
employees maintain wellness programs.153  Most wellness programs include 
a health risk assessment and a significant number solicit information relating 
to family history.154  For example, when assessing whether someone is at risk 
for Type II diabetes, the assessment may ask about height, weight, and 
whether there is a family history of Type II diabetes. 
The proposed regulations for GINA impose prerequisites to the 
acquisition of genetic information in connection with a voluntary wellness 
program.155  The employee participating in the wellness program must 
provide knowing, voluntary, and written authorization which must be 
understandable.156  The authorization must describe the genetic information 
that will be obtained, and describe the restrictions on disclosure of the 
 
 149. Regulations Under the Genetic Nondiscrimination Act of 2008, 74 Fed. Reg. 9056, 
9063 (proposed Mar. 2, 2009). 
 150. Genetic Discrimination: EEOC Receives Varying Advice on Tweaking Its Proposed 
Rules Under Genetic Bias Law, supra note 116. 
 151. GINA, Pub. L. No. 110-233, §§ 202-05, 122 Stat. 881, 907, 909-10, 912 (2008) 
(to be codified at 42 U.S.C. §§ 2000ff-1(b)(2), 2000ff-2(b)(2), 2000ff-3(b)(2), 2000ff-4(b)(2)). 
 152. See Lisa Phillips, Wellness in the Workplace: How and Why to Take Advantage of 
Preventive Care Coverage, NEUROLOGY NOW, July-Aug. 2009, at 32, 33. 
 153. Laura Petrecca, Companies Re-Evaluate Wellness Programs, USA TODAY, June 19, 
2009, at 3B, available at http://www.usatoday.com/money/workplace/2009-06-16-wellness-
programs-companies_N.htm. 
 154. See Phillips, supra note 152, at 32. 
 155. Regulations Under the Genetic Information Nondiscrimination Act of 2008, 74 Fed. 
Reg. 9056, 9062, 9068-69 (proposed Mar. 2, 2009) (to be codified at 29 C.F.R. pt. 
1635.8(b)(2)). 
 156. Regulations Under the Genetic Information Nondiscrimination Act of 2008, 74 Fed. 
Reg. at 9062, 9068 (to be codified at 29 C.F.R. pt. 1635.8(b)(2)(i)(A)). 
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information.157  The results of this analysis can be disclosed to the employer 
only in aggregate terms.158 
Before the exception for genetic information obtained in connection with 
a wellness program applies, participation in the program must be 
voluntary.159  Wellness programs may even be hinged on incentives.160  
Some incentives, though, arguably can operate like penalties, such as when 
an employer makes availability of health insurance contingent on 
participation in a wellness program.161  The EEOC Guidance on the ADA, 
which also considers the receipt of medical information in connection with 
voluntary wellness programs, says that programs are voluntary “as long as 
an employer neither requires participation nor penalizes employees who do 
not participate.”162  The EEOC has not yet answered the question of when 
an “incentive” might become such a “penalty” as to make the wellness 
program involuntary.  In its NPRM, the EEOC noted that this is an area in 
which it has not yet spoken and therefore invited comment.163  It received a 
number of comments on this issue, with employer representatives and 
benefits groups asserting that the EEOC should incorporate the Health 
 
 157. Regulations Under the Genetic Information Nondiscrimination Act of 2008, 74 Fed. 
Reg. at 9062, 9068 (to be codified at 29 C.F.R. pt. 1635.8(b)(2)(i)(B)-(C)). 
 158. Regulations Under the Genetic Information Nondiscrimination Act of 2008, 74 Fed. 
Reg. at 9062, 9069 (to be codified at 29 C.F.R. pt. 1635.8(b)(2)(iii)). 
 159. Regulations Under the Genetic Information Nondiscrimination Act of 2008, 74 Fed. 
Reg. at 9062, 9068 (to be codified at 29 C.F.R. pt. 1635.8(b)(2)(i)). 
 160. See Petrecca, supra note 153. 
 161. See e.g., U.S. Equal Employment Opportunity Comm’n, EEOC Informal Discussion 
Letter: ADA: Disability-Related Inquiries and Medical Examinations; Health Risk Assessment 
(March 6, 2009), http://www.eeoc.gov/eeoc/foia/letters/2009/ada_disability_medexam_ 
healthrisk.html. 
 162. EEOC ADA ENFORCEMENT GUIDANCE, supra note 77, at 14; see also U.S. Equal 
Employment Opportunity Comm’n, supra note 161 (an informal opinion letter concluding that 
the requirement that employee participate in health risk assessment as a condition to qualify 
for participation in the employer health plan was not “voluntary” under the ADA.)  “Thus, even 
if the health risk assessment could be considered part of a wellness program, the program 
would not be voluntary, because individuals who do not participate in the assessment are 
denied a benefit (i.e., penalized for non-participation) as compared to employees who 
participate in the assessment.”  Id. 
 163. Regulations Under the Genetic Information Nondiscrimination Act of 2008, 74 Fed. 
Reg. 9056, 9062 (proposed Mar. 2, 2009); see also EEOC, Questions for the EEOC Staff for 
the 2006 Joint Committee of Employee Benefits Technical Session (May 4, 2006) 
http://www.abanet.org/jceb/2006/EEOC2006final.pdf (providing nonbinding responses 
concerning Wellness Programs “if the [wellness] program requires employees to answer 
disability-related inquiries or submit to medical examinations, participation in the program 
must be voluntary”).  “[A] wellness program is ‘voluntary’ (thus disability-related questions and 
medical examinations are permitted) if the employer neither requires participation nor 
penalizes employees for non-participation in the program.” EEOC, Id. 
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Insurance Portability and Accountability Act (HIPAA)164 non-discrimination 
standard.165  Under this standard, a group health plan does not violate the 
non-discrimination provisions of HIPAA if it maintains a wellness program 
under which, among other things, the rewards offered for participation in 
the program are not greater than twenty percent of the cost of employee-
only coverage under the group health plan, or, if dependants can also 
participate in the wellness program, twenty percent of the cost of coverage 
in which the employee and dependants are enrolled.166  On the other hand, 
employee and privacy organizations, as well as the Genetics and Public 
Policy Center, contend that any financial inducement offered to the 
employee to participate in the wellness program should not be considered 
“voluntary.”167  The resolution of this dispute could have an impact on the 
structure of wellness programs generally, because the ADA contains a 
similar requirement that wellness programs be “voluntary.”168 
Finally, in addition to GINA provisions relating to the acquisition of 
genetic information, the statute provides that a covered entity cannot 
discriminate based upon genetic information that it has acquired.169  GINA 
 
 164. Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191, 
110 Stat. 1936 (1996) (codified at 42 U.S.C. § 1320d (2000)). 
 165. See Genetic Discrimination: EEOC Receives Varying Advice on Tweaking Its Proposed 
Rules Under Genetic Bias Law, supra note 116. 
 166. 29 C.F.R. § 2590.702(f)(2) (2008). 
 167. Genetic Discrimination: EEOC Receives Varying Advice on Tweaking Its Proposed 
Rules Under Genetic Bias Law, supra note 116. 
 168. On October 7, 2009, the Labor Department, Centers for Medicare and Medicaid, 
and Internal Revenue Service published interim final rules to Title I of GINA, which covers 
health plans.  Sean Forbes, Health Care: IRS, Labor, CMS Issue Interim Rules Implementing 
GINA, Request Comments, [2009] Daily Lab. Rep. (BNA) No. 189, at A-18 (Oct. 2, 2009).  
The interim final rules will, if adopted, prohibit covered entities from obtaining genetic 
information in any wellness program that uses rewards in health benefit premiums:  
GINA prohibits collecting genetic information for underwriting purposes. As described 
earlier, underwriting purposes is defined broadly to include rules for eligibility for 
benefits and the computation of premium or contributions amounts, and not merely 
activities relating to rating and pricing a group policy. Moreover, GINA defines genetic 
information as including family medical history. Consequently, wellness programs that 
provide rewards for completing [Health Risk Assessments] that request genetic 
information, including family medical history, violate the prohibition against requesting 
genetic information for underwriting purposes. This is the result even if rewards are not 
based on the outcome of the assessment, which otherwise would not violate the 2006 
final HIPAA nondiscrimination rules regarding wellness programs. 
Interim Final Rules Prohibiting Discrimination Based on Genetic Information in Health 
Insurance Coverage and Group Health Plans, 74 Fed. Reg. 51,664, 51,668 (proposed Oct. 
7, 2009) (to be codified at 45 C.F.R. pts. 144, 146, and 148). 
 169. GINA, Pub. L. No. 110-233, §§ 202-05, 122 Stat. 881, 907, 908, 910, 911 (2008) 
(to be codified at 42 U.S.C. §§ 2000ff-1(a), 2000ff-2(a), 2000ff-3(a), 2000ff-4(a)). 
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provides no defenses for an entity that discriminates against an employee 
based upon genetic information, regardless of how the information was 
obtained.  There is, for example, no “bona fide occupational qualification” 
or BFOQ defense.  In a statement issued concurrently with its NPRM, the 
EEOC wrote: 
Q: Are there any exceptions to the prohibition on the use of genetic 
information? 
A: No.  This prohibition is absolute.  Covered entities may not use genetic 
information in making employment decisions under any circumstances.170 
GINA does not extend to manifested conditions.171  Under the NPRM, 
someone has a “manifested” condition when “that . . . individual has or 
could reasonably be diagnosed with the disease, disorder, or pathological 
condition by a health care professional with appropriate training and 
expertise in the field of medicine involved.”172  A disease is not manifested 
“if the diagnosis is based principally on genetic information or on the results 
of one or more genetic tests.”173  So, a person who has no manifestation of 
the condition is protected against discrimination by GINA.  One whose 
condition is fully developed may be covered by the ADA as amended.  The 
problem is whether people might fall through a gap between unmanifested 
and fully manifested conditions. 
IV.  PROBLEMS REMAINING AFTER GINA 
GINA does not resolve all concerns over genetic testing or 
discrimination.  The potential gap is a problem that is raised by many 
commentators.174  Are there people who would be covered by GINA when 
the condition was nascent, and who would be covered by the ADA when it is 
 
 170. U.S. Equal Employment Opportunity Comm’n, Background Information for EEOC 
Notice of Proposed Rulemaking on Title II of the Genetic Information Nondiscrimination Act of 
2008, http://www.eeoc.gov/policy/docs/qanda_geneticinfo.html (last visited Feb. 11, 2010). 
 171. GINA §210, 122 Stat. at 920 (to be codified at 42 U.S.C. § 2000ff-9) (“An 
employer, employment agency, labor organization, or joint labor-management committee 
shall not be considered to be in violation of this title based on the use, acquisition, or 
disclosure of medical information that is not genetic information about a manifested disease, 
disorder, or pathological condition of an employee or member, including a manifested 
disease, disorder, or pathological condition that has or may have a genetic basis.”). 
 172. Regulations Under the Genetic Information Nondiscrimination Act of 2008, 74 Fed. 
Reg. 9056, 9059-60, 9068 (proposed Mar. 2, 2009) (to be codified at 29 C.F.R. pt. 
1635.3(g)). 
 173. Regulations Under the Genetic Information Nondiscrimination Act of 2008, 74 Fed. 
Reg. at 9059-60, 9068 (to be codified at 29 C.F.R. pt. 1635.3(g)). 
 174. See, e.g., Rothstein, supra note 93, at 838-39 (noting that “individuals with a genetic 
predisposition to future illness are probably not covered by the ADA” even after the ADAAA). 
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full-blown, but who fall through a gap when their condition falls somewhere 
in the middle? 
Whether there is, in fact, a gap will largely depend on how the courts 
interpret the amendments to the ADA.  With the ADAAA, there is a colorable 
argument if someone is discriminated against because of the presence of a 
genetic condition, even if that condition is presenting only slightly, that the 
employer regarded the individual as having an impairment, thereby invoking 
ADA’s coverage.175 
However, the coverage of GINA is not all-encompassing, and may not 
have the benefit of encouraging people to engage in genetic counseling 
and testing as is hoped.  Life and disability insurance are not covered, for 
example.176  Discrimination in such areas occurs.177  A study from Australia 
in early 2009 surveyed cases of persons who had undergone genetic testing 
and who were subsequently denied life insurance.178  A five year study 
through the Genetic Discrimination Project found that ten percent of more 
than 1,000 people who received a genetic test subsequently experienced 
some sort of discrimination.179 
GINA also does not have the scope of some other antidiscrimination 
laws, such as the Civil Rights Act of 1964 and the ADA, which reach public 
accommodations and programs.  Nothing in GINA, for example, would 
stop a private intramural athletic program from adopting a screening 
process aimed at identifying young athletes carrying genes that potentially 
 
 175. See supra text accompanying notes 102-12. 
 176. Rothstein, supra note 16, at 9 (“GINA does nothing to prohibit discrimination in life 
insurance, disability insurance, long-term care insurance, mortgages, commercial 
transactions, or any of the other possible uses of genetic information.”). 
 177. See, e.g., Myk Cherskov, Fighting Genetic Discrimination, A.B.A. J., June 1992, at 
38, 38 (noting how an individual was denied disability insurance because her father suffered 
from Huntington’s disease); Kristine Barlow-Stewart et al., Verification of Consumers’ 
Experiences and Perceptions of Genetic Discrimination and Its Impact on Utilization of Genetic 
Testing, 11 GENETICS MED. 193, 200 (2009) (analyzing genetic discrimination in life insurance 
coverage). 
 178. Barlow-Stewart, supra note 177, at 195, 200. 
 179. ABC News, Research Finds Evidence of Genetic Discrimination, ABC NEWS, Mar. 10, 
2009, http://www.abc.net.au/news/stories/2009/03/10/2511689.htm?section=justi; see 
also Genetic Discrimination Project, Reports & Papers (listing papers and reports of the 
Genetic Discrimination Project), http://www.gdproject.org/reports/index.php (last visited Feb. 
11, 2010).  Australia has been on the forefront of examining whether genetic testing leads to 
differential treatment in insurance and employment.  Kristine Barlow-Stewart, Genetic 
Discrimination: Australian Experiences and Policies, GENEWATCH, Apr.-May 2009, at 15, 15-
17.  On the employment front, it found little evidence that genetic information was 
systemically being used to discriminate.  An important distinction between employment in 
Australia and the United States, however, is that health insurance is not tied to employment in 
Australia.  Instead, Australia has a national health plan and private insurance is not risk-rated.  
Id. 
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put them at higher risk for sudden heart attacks,180 or alternatively, to 
identify those candidates whose genetic profile indicates that they might 
make better athletes.181  Although other checks may exist, they are not found 
in GINA. 
The military is not included, even though it has been accused of genetic 
discrimination.182  Elected officials are also not covered.  There is nothing 
that stops an intrepid reporter from picking up some discarded gum and 
sending it off to a facility like 23andme183 to obtain information about a 
presidential candidate’s genetics.184 
 
 180. Cf. Kathleen Fackelmann, Flaws of the Heart: Sudden Death in Athletes Is Often 
Caused by Cardiac Defects, 150 SCI. NEWS, 76, 77 (1996) (discussing the need for screening 
of athletes for heart conditions), available at http://www.sciencenews.org/pages/pdfs/data/ 
1996/150-05/15005-16.pdf; Heart Hospital of N.M. Found., Heart of a Champion Teen 
Athlete Screening Program (offering free ECG to test for hypertropic cardiomyopathy for 
student athletes), http://www.hhnmfoundation.org/programs_heart.php.  In 2005, the 
Chicago Bulls demanded center Eddy Curry, who was a restricted free agent, take a genetic 
test for susceptibility to hypertrophic cardiomyopathy (HCM) as a condition for extending his 
contract.  Associated Press, Bulls Ship Curry to Knicks, N.Y. TIMES.COM, Oct. 3, 2005, 
http://www.nytimes.com/2005/10/03/sports/basketball/04curry-wire.html?_r=1.  Curry 
refused, and ultimately, after a lengthy standoff, the Bulls traded Curry to the Knicks.  Id. 
 181. Juliet Macur, Born to Run? Little Ones Get Test for Sports Gene, N.Y. TIMES, Nov. 30, 
2008 at A1 (discussing genetic tests that aim to predict children’s athletic strengths).  See 
generally Sports Law Blog, Update on MLB’s Use of Genetic Testing (July 24, 2009) 
(discussing DNA testing in sports), http://sports-law.blogspot.com/2009/07/update-on-mlbs-
use-of-genetic-testing.html.  An interesting issue has recently arisen with regard to Major 
League Baseball conducting genetic tests of potential Latin American players to determine 
paternity/maternity of the player.  See Michael S. Schmidt & Alan Schwarz, Baseball’s Use of 
DNA Tests on Prospects Finds Controversy, Too, N.Y. TIMES, July 22, 2009, at A1.  The results 
are part of an effort to verify the players’ age and identity, and prevent older players from 
passing themselves off as younger.  Id.  The possibility of the genetic information being used 
to screen persons out because of perceived risk of future disease is evident.  As the scouting 
director for one team stated, “It’s a tough area to figure morally and in all kinds of directions,” 
he said. “Can they test susceptibility to cancer? I don’t know if they’re doing any of that. But I 
know they’re looking into trying to figure out susceptibility to injuries, things like that. If they 
come up with a test that shows someone’s connective tissue is at a high risk of not holding up, 
can that be used? I don’t know. I do think that’s where this is headed.”  Id.  See also Dan 
Vorhaus, MLB Meets GINA, GENOMICS L. REP. (July 22, 2009) (further discussing genetic 
testing in Major League Baseball), http://www.genomicslawreport.com/index.php/2009/07/ 
22/mlb-meets-gina/. 
 182. See Karen Kaplan, U.S. Military Practices Genetic Discrimination in Denying Benefits, 
L.A. TIMES, Aug.18, 2007, at A1 (discussing how the U.S. military has denied disability benefits 
for servicemen and woman who have congenital or hereditary conditions). 
 183. 23andMe, Inc., Home Page (an online service that provides direct-to-consumer 
genetic testing), https://www.23andme.com/ (last visited Feb. 11, 2010). 
 184. See Teneille R. Brown, Double Helix, Double Standards: Private Matters and Public 
People, 11 J. HEALTH CARE L. & POL’Y 295, 299 (2008). 
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State entities are currently covered by the employment provisions of 
GINA,185 and Congress did include findings regarding state conduct, such 
as sterilization for presumed “genetic” defects.186  It seems likely, though, 
that eventually there will be an Eleventh Amendment challenge to private 
causes of action against state entities for monetary relief.  Prior challenges 
under the Age Discrimination in Employment Act and the ADA were 
successful, although the EEOC, as the federal enforcement agency, retains 
its authority to bring suit even if the private cause of action was limited.187 
So GINA should not stop the discussion.  We have to consider, as 
members of a society, what we are going to permit.  And even if we are 
going to permit it, what safeguards do we need?  Right now, the safeguards 
on genetic testing, which are becoming increasingly available through 
online commercial sources, are not heavily regulated, and some would say 
such tests are not effectively regulated at all.188 
CONCLUSION 
The hope for GINA is that it cuts down, if not outright eliminates, genetic 
discrimination in employment, before it takes root.  This will be different 
from any other federal anti-discrimination statute.  Race discrimination, 
religious discrimination, sex discrimination, age discrimination, national 
origin discrimination, disability discrimination—all were well established 
before the laws prohibiting them were passed. 
It is not the same with genetic discrimination.  GINA is getting in on the 
ground floor.  There remain numerous areas in which discrimination based 
on genetics can occur, however, and as a society, we need to continue to 
balance the needs of discovery against the needs for protection of individual 
privacy and protection against unwarranted discrimination.  The public 
debate about the role of genetics in our lives will continue. 
 
 185. GINA, Pub. L. No. 110-233, § 201, 122 Stat. 881, 906 (2008) (to be codified at 42 
U.S.C. § 2000ff(2)(B)(ii)). 
 186. GINA § 2, 122 Stat. at 882 (to be codified at 42 U.S.C. § 2000ff note). 
 187. Bd. of Trs. of Univ. of Ala. v. Garrett, 531 U.S. 356, 363 (2001); Kimel v. Fla. Bd. of 
Regents, 528 U.S. 62, 91-92 (2000). 
 188. Bruce Patsner, New “Home Brew” Predictive Genetic Tests Present Significant 
Regulatory Problems, 9 HOUS. J. HEALTH L. & POL’Y 237, 240-41 (2009) (discussing the lack 
of and need for oversight of predictive genetic testing kits and on-line commercial genome 
testing companies). 
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